Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (3y) (2017 - 2026)
Tandem Diabetes Care (TNDM) Return on Capital Employed Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -1,679.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -846.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,318.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -247.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn | 1,377.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,377.00 |
| Dec 31, 2025 | -1,899.00 |
| Sep 30, 2025 | -2,432.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -2,843.00 |
| Dec 31, 2024 | -1,689.00 |
| Sep 30, 2024 | -2,347.00 |
| Jun 30, 2024 | -2,288.00 |
| Mar 31, 2024 | -1,989.00 |
| Dec 31, 2023 | -2,971.00 |
| Sep 30, 2023 | -2,402.00 |
| Jun 30, 2023 | -2,183.00 |
| Mar 31, 2023 | -1,646.00 |
| Dec 31, 2022 | -253.00 |
| Sep 30, 2022 | 337.00 |
| Jun 30, 2022 | 1,779.00 |
| Mar 31, 2022 | 3,127.00 |
| Dec 31, 2021 | 3,800.00 |
| Sep 30, 2021 | 5,330.00 |
| Jun 30, 2021 | 5,097.00 |